Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Journal articles

Wong A; Hoffman RS; Walsh SJ; Roberts DM; Gosselin S; Bunchman TE; Kebede S; Lavergne V; Ghannoum M; Alhatali B; Anseeuw K; Berling I; Bouchard J; Bird S; Chin P; Doi K; Galvao T; Goldfarb D; Hassanian H; Hoegberg L; Kallab S; Kielstein J; Li Y; Macedo E; MacLaren R; Megarbane B; Mowry J; Nolin TD; Osterman M; Peng A; Roy JP; Vijayan A; Wood D; Yates C, 2021, 'Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup', Clinical Toxicology, 59, pp. 361 - 375, http://dx.doi.org/10.1080/15563650.2020.1870123

Bode MJF; Premachandra KH; Roberts DM, 2021, 'Increases in NT-proBNP in the poisoned patient are probably multifactorial', Clinical Toxicology, 59, pp. 1035 - 1036, http://dx.doi.org/10.1080/15563650.2021.1955915

Premachandra KH; Roberts DM, 2021, 'Poor relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and level of consciousness following intentional ingestion of eucalyptus oil', Clinical Toxicology, 59, pp. 1033 - 1034, http://dx.doi.org/10.1080/15563650.2021.1887884

Stefani M; Fulde S; McCrohon J; Roberts DM, 2020, 'Transient accelerated idioventricular rhythm after 1,4-butanediol exposure', Clinical Toxicology, 58, pp. 1071 - 1072, http://dx.doi.org/10.1080/15563650.2020.1728296

Berling I; King JD; Shepherd G; Hoffman RS; Alhatali B; Lavergne V; Roberts DM; Gosselin S; Wilson G; Nolin TD; Ghannoum M; Anseeuw K; Bird S; Bunchman T; Bouchard J; Calello D; Chin P; Doi K; Galvao T; Goldfarb D; Hassanian H; Hoegberg L; Kallab S; Kebede S; Kielstein J; Lewington A; Li Y; Macedo E; MacLaren R; Megarbane B; Mowry J; Osterman M; Peng A; Roy JP; Vijayan A; Walsh S; Wong A; Wood D; Yates C, 2020, 'Extracorporeal treatment for chloroquine, hydroxychloroquine, and quinine poisoning: Systematic review and recommendations from the EXTRIP workgroup', Journal of the American Society of Nephrology, 31, pp. 2475 - 2489, http://dx.doi.org/10.1681/ASN.2020050564

Athavale A; Jamshidi N; Roberts DM, 2020, 'Incomplete responses to the recommended dose of idarucizumab: a systematic review and pharmacokinetic analysis', Clinical Toxicology, 58, pp. 789 - 800, http://dx.doi.org/10.1080/15563650.2020.1743846

Athavale A; Roberts DM, 2020, 'Management of proteinuria: Blockade of the renin–angiotensin–aldosterone system', Australian Prescriber, 43, pp. 121 - 125, http://dx.doi.org/10.18773/austprescr.2020.021

Roberts DM; Bennett A, 2020, 'Covid-19 and the quality use of medicines: Evidence, risks and fads', Australian Prescriber, 43, pp. 78 - 80, http://dx.doi.org/10.18773/austprescr.2020.031

Ghannoum M; Hoffman RS; Roberts DM; Lavergne V; Nolin TD; Gosselin S, 2020, 'Hemodialysis removal of caffeine', American Journal of Emergency Medicine, 38, pp. 1273 - 1274, http://dx.doi.org/10.1016/j.ajem.2020.02.033

Roberts DM; Hoffman RS, 2020, 'Consensus statements for clinical practice require rigorous and transparent methods', Pediatric Nephrology, 35, pp. 911 - 912, http://dx.doi.org/10.1007/s00467-019-04407-3

Stefani M; Roberts DM; Brett J, 2020, 'High-dose insulin euglycemic therapy to treat cardiomyopathy associated with massive venlafaxine overdose', Clinical Toxicology, 58, pp. 299 - 300, http://dx.doi.org/10.1080/15563650.2019.1638930

Athavale A; Athavale T; Roberts DM, 2020, 'Antiemetic drugs: What to prescribe and when', Australian Prescriber, 43, pp. 49 - 56, http://dx.doi.org/10.18773/austprescr.2020.011

Stefani M; Roberts DM, 2020, '1,4-Butanediol overdose mimicking toxic alcohol exposure', Clinical Toxicology, 58, pp. 204 - 207, http://dx.doi.org/10.1080/15563650.2019.1617419

Roberts DM, 2020, 'Metabolic complications of poisoning', Medicine (United Kingdom), 48, pp. 169 - 172, http://dx.doi.org/10.1016/j.mpmed.2019.12.005

Berling I; Hatten BW; Hoffman RS; Othong R; Roberts DM; Mustafa RA; Yates C; Cormier M; Gosselin S, 2020, 'Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose', Clinical Toxicology, 58, pp. 20 - 28, http://dx.doi.org/10.1080/15563650.2019.1605077

Beirne P; Roberts DM, 2020, 'Estimating renal function for patients in wheelchairs.', Aust Prescr, 43, pp. 67, http://dx.doi.org/10.18773/austprescr.2020.020

Chiew AL; Domingo G; Buckley NA; Stathakis P; Ress K; Roberts DM, 2020, 'Hepatotoxicity in a child following an accidental overdose of liquid paracetamol.', Clin Toxicol (Phila), 58, pp. 1063 - 1066, http://dx.doi.org/10.1080/15563650.2020.1722150

Cashman H; Joseph J; Roberts D, 2020, 'Idarucizumab resistance due to a markedly elevated dabigatran concentration – A case report', Pathology, 52, pp. S108 - S109, http://dx.doi.org/10.1016/j.pathol.2020.01.372

2020, 'QUM and COVID-19 in young adults.', Aust Prescr, 43, pp. 110, http://dx.doi.org/10.18773/austprescr.2020.038

Hassanian-Moghaddam H; Zamani N; Roberts DM; Brent J; McMartin K; Aaron C; Eddleston M; Dargan PI; Olson K; Nelson L; Bhalla A; Hantson P; Jacobsen D; Megarbane B; Balali-Mood M; Buckley NA; Zakharov S; Paasma R; Jarwani B; Mirafzal A; Salek T; Hovda KE, 2019, 'Consensus statements on the approach to patients in a methanol poisoning outbreak', Clinical Toxicology, 57, pp. 1129 - 1136, http://dx.doi.org/10.1080/15563650.2019.1636992

Stefani M; Singer RF; Roberts DM, 2019, 'How to adjust drug doses in chronic kidney disease', Australian Prescriber, 42, pp. 163 - 167, http://dx.doi.org/10.18773/austprescr.2019.054

Campion GH; Wang JJ; Hoffman RS; Cormier M; Lavergne V; Mowry JB; Roberts DM; Ghannoum M; Su MK; Gosselin S, 2019, 'Extracorporeal treatments in poisonings from four non-traditionally dialysed toxins (acetaminophen, digoxin, opioids and tricyclic antidepressants): A combined single-centre and national study', Basic and Clinical Pharmacology and Toxicology, 124, pp. 341 - 347, http://dx.doi.org/10.1111/bcpt.13135

Stefani M; Roberts DM, 2018, 'Complex decisions in the use of extracorporeal treatments in acute metformin overdose: which modality, when and how to measure the effect', British Journal of Clinical Pharmacology, 84, pp. 2689 - 2691, http://dx.doi.org/10.1111/bcp.13762

Tay EMY; Roberts DM, 2018, 'A spotlight on the role, use, and availability of codeine and the implications faced', Expert Review of Clinical Pharmacology, 11, pp. 1057 - 1059, http://dx.doi.org/10.1080/17512433.2018.1537122

Ghannoum M; Hoffman RS; Gosselin S; Nolin TD; Lavergne V; Roberts DM, 2018, 'Use of extracorporeal treatments in the management of poisonings', Kidney International, 94, pp. 682 - 688, http://dx.doi.org/10.1016/j.kint.2018.03.026

Lavergne V; Gosselin S; Ghannoum M; Hoegberg LC; Roberts DM, 2018, 'Extracorporeal blood purification for treating acute paraquat poisoning', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD013112

Christiadi D; Singer RF; Roberts DM, 2018, 'Successful treatment of PD peritonitis due to brevundimonas vesicularis', Peritoneal Dialysis International, 38, pp. 379 - 381, http://dx.doi.org/10.3747/pdi.2018.00014

Roberts DM; Sevastos J; Carland JE; Stocker SL; Lea-Henry TN, 2018, 'Clinical pharmacokinetics in kidney disease application to rational design of dosing regimens', Clinical Journal of the American Society of Nephrology, 13, pp. 1254 - 1263, http://dx.doi.org/10.2215/CJN.05150418

Tirumala-Echampati K; Roberts DM, 2018, 'Communication and ciprofloxacin-associated acute kidney injury', Australian Prescriber, 41, pp. 122, http://dx.doi.org/10.18773/austprescr.2018.035

Lea-Henry TN; Carland JE; Stocker SL; Sevastos J; Roberts DM, 2018, 'Clinical pharmacokinetics in kidney disease: Fundamental principles', Clinical Journal of the American Society of Nephrology, 13, pp. 1085 - 1095, http://dx.doi.org/10.2215/CJN.00340118

Wan SS; Ying TD; Wyburn K; Roberts DM; Wyld M; Chadban SJ, 2018, 'The treatment of antibody-mediated rejection in kidney transplantation: An updated systematic review and meta-analysis', Transplantation, 102, pp. 557 - 568, http://dx.doi.org/10.1097/TP.0000000000002049

Roberts DM; Nielsen S, 2018, 'Changes for codeine', Australian Prescriber, 41, pp. 2 - 3, http://dx.doi.org/10.18773/austprescr.2018.006

Lea-Henry TN; Baird-Gunning J; Petzel E; Roberts DM, 2017, 'Medication management on sick days', Australian Prescriber, 40, pp. 168 - 173, http://dx.doi.org/10.18773/austprescr.2017.057

Ai P; Kaiyuan Z; Xinhua L; Changbin L; Buckley NA; Roberts DM, 2017, 'Extracorporeal blood purification for organophosphorus pesticide poisoning', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD006253.pub2

Roberts DM; Lea-Henry TN, 2017, 'Simplifying the hemodialysis prescription in patients with ethylene glycol poisoning', Kidney International, 92, pp. 291 - 293, http://dx.doi.org/10.1016/j.kint.2017.03.051

Baird-Gunning J; Lea-Henry T; Hoegberg LCG; Gosselin S; Roberts DM, 2017, 'Lithium Poisoning', Journal of Intensive Care Medicine, 32, pp. 249 - 263, http://dx.doi.org/10.1177/0885066616651582

Zakharov S; Roberts DM; Hovda KE, 2017, 'Reply to “Letter in response to efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning”', Clinical Toxicology, 55, pp. 306 - 307, http://dx.doi.org/10.1080/15563650.2017.1284338

Bouchard J; Lavergne V; Roberts DM; Cormier M; Morissette G; Ghannoum M, 2017, 'Availability and cost of extracorporeal treatments for poisonings and other emergency indications: A worldwide survey', Nephrology Dialysis Transplantation, 32, pp. 699 - 706, http://dx.doi.org/10.1093/ndt/gfw456

Zakharov S; Pelclova D; Navratil T; Belacek J; Latta J; Pisar M; Rulisek J; Leps J; Zidek P; Kucera C; Bocek R; Mazur M; Belik Z; Chalupa J; Talafa V; Kodras K; Nalos D; Sedlak C; Senkyrik M; Smid J; Salek T; Roberts DM; Hovda KE, 2017, 'Efficiency of acidemia correction on intermittent versus continuous hemodialysis in acute methanol poisoning', Clinical Toxicology, 55, pp. 123 - 132, http://dx.doi.org/10.1080/15563650.2016.1250901

Lavergne V; Hoffman RS; Mowry JB; Cormier M; Gosselin S; Roberts DM; Ghannoum M, 2016, 'Why are we Still Dialyzing Overdoses to Tricyclic Antidepressants? A subanalysis of the NPDS database', Seminars in dialysis, 29, pp. 403 - 409, http://dx.doi.org/10.1111/sdi.12520

Kennard A; Roberts DM, 2016, 'Trimethoprim-induced critical hyperkalaemia', Australian Prescriber, 39, pp. 136 - 137, http://dx.doi.org/10.18773/austprescr.2016.050

Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA, 2016, 'Pharmacokinetics of intraperitoneal cefalothin and cefazolin in patients being treated for peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 36, pp. 415 - 420, http://dx.doi.org/10.3747/pdi.2015.00008

Parker SL; Guerra Valero YC; Roberts DM; Lipman J; Roberts JA; Wallis SC, 2016, 'Determination of Cefalothin and Cefazolin in Human Plasma, Urine and Peritoneal Dialysate by UHPLC-MS/MS: Application to a pilot pharmacokinetic study in humans', Biomedical Chromatography, 30, pp. 872 - 879, http://dx.doi.org/10.1002/bmc.3622

Singer RF; Williams O; Mercado C; Chen B; Talaulikar G; Walters G; Roberts DM, 2016, 'Regional citrate anticoagulation in hemodialysis: An observational study of safety, efficacy, and effect on calcium balance during routine care', Canadian Journal of Kidney Health and Disease, 3, http://dx.doi.org/10.1186/s40697-016-0113-x

Roberts DM; Gallapatthy G; Dunuwille A; Chan BS, 2016, 'Pharmacological treatment of cardiac glycoside poisoning', British Journal of Clinical Pharmacology, 81, pp. 488 - 495, http://dx.doi.org/10.1111/bcp.12814

Roberts JA; Choi GYS; Joynt GM; Paul SK; Deans R; Peake S; Cole L; Stephens D; Bellomo R; Turnidge J; Wallis SC; Roberts MS; Roberts DM; Lassig-Smith M; Starr T; Lipman J, 2016, 'SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): An observational pharmacokinetic study in critically ill patients', BMC Infectious Diseases, 16, http://dx.doi.org/10.1186/s12879-016-1421-6

Juurlink DN; Gosselin S; Kielstein JT; Ghannoum M; Lavergne V; Nolin TD; Hoffman RS; Anseeuw K; Bhalla A; Burdmann EA; Calello DP; Dargan PI; Decker BS; Goldfarb DS; Galvo T; Hoegberg LC; Laliberté M; Li Y; Liu KD; MacLaren R; MacTier R; Mégarbane B; Mowry JB; Phan V; Roberts DM; Wiegand TJ; Winchester JF; Yates C, 2015, 'Extracorporeal treatment for salicylate poisoning: Systematic review and recommendations from the EXTRIP workgroup', Annals of Emergency Medicine, 66, pp. 165 - 181, http://dx.doi.org/10.1016/j.annemergmed.2015.03.031

Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KGC; Jayne DRW, 2015, 'Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis', Rheumatology (United Kingdom), 54, pp. 1153 - 1160, http://dx.doi.org/10.1093/rheumatology/keu452

Roberts DM; Hoffman RS; Gosselin S; Megarbane B; Yates C; Ghannoum M, 2015, 'The authors reply', Critical Care Medicine, 43, pp. e211 - e212, http://dx.doi.org/10.1097/CCM.0000000000001006

Ghannoum M; Laliberté M; Nolin TD; Mactier R; Lavergne V; Hoffman RS; Gosselin S; Anseeuw K; Bhalla A; Burdmann EA; Calello DP; Dargan PI; Decker BS; Galvao TF; Goldfarb DS; Hoegberg LC; Juurlink DN; Li Y; Liu KD; MacLaren R; Mégarbane B; Mowry JB; Phan V; Roberts DM; Sowinski KM; Wiegand TJ; Winchester JF; Yates C, 2015, 'Extracorporeal treatment for valproic acid poisoning: Systematic review and recommendations from the EXTRIP workgroup', Clinical Toxicology, 53, pp. 454 - 465, http://dx.doi.org/10.3109/15563650.2015.1035441


Back to profile page